» Authors » Sara Falivene

Sara Falivene

Explore the profile of Sara Falivene including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 344
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Leonardi M, Pepa M, Zaffaroni M, Vincini M, Luraschi R, Vigorito S, et al.
Tumori . 2023 Sep; 109(6):570-575. PMID: 37688419
This study quantified the incidental dose to the first axillary level (L1) in locoregional treatment plan for breast cancer. Eighteen radiotherapy centres contoured L1-L4 on three different patients (P1,2,3), created...
2.
Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, et al.
Tumori . 2022 Sep; 108(2_suppl):1-144. PMID: 36112842
Introduction: Breast cancer is the most common tumor in women and represents the leading cause of cancer death. Radiation therapy plays a key-role in the treatment of all breast cancer...
3.
Ciabattoni A, Gregucci F, DErmo G, Dolfi A, Cucciarelli F, Palumbo I, et al.
Cancers (Basel) . 2022 Aug; 14(16). PMID: 36010920
Breast IRRADIATA (Italian Repository of RADIotherapy dATA) is a collaborative nationwide project supported by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) and the Italian League Against Cancer (LILT)....
4.
Nardone V, Falivene S, Giugliano F, Gaetano M, Giordano P, Muto M, et al.
Transl Cancer Res . 2022 Feb; 9(Suppl 1):S97-S109. PMID: 35117951
The focus of this review deals with the management of elderly patients with early stage breast cancer, discussing the role of systemic therapies [endocrine therapy (ET), chemotherapy, novel agents] and...
5.
Palumbo I, Borghesi S, Gregucci F, Falivene S, Fontana A, Aristei C, et al.
J Geriatr Oncol . 2021 May; 12(7):1130-1135. PMID: 34020908
This review is aimed at evaluating whether radiation therapy (RT) can be omitted in older adult early-stage low-risk breast cancer (BC) patients. The published data are particularly relevant at present,...
6.
Borzillo V, Di Franco R, Giannarelli D, Cammarota F, Scipilliti E, DIppolito E, et al.
Cancers (Basel) . 2021 Apr; 13(8). PMID: 33924595
The median overall survival (OS) and local control (LC) of patients with melanoma brain metastases (MBMs) are poor even with immune checkpoint inhibitors and/or radiotherapy (RT). The aims of the...
7.
Leonardi M, Pepa M, Gugliandolo S, Luraschi R, Vigorito S, Rojas D, et al.
Br J Radiol . 2021 Apr; 94(1123):20201177. PMID: 33882239
Objectives: To determine interobserver variability in axillary nodal contouring in breast cancer (BC) radiotherapy (RT) by comparing the clinical target volume of participating single centres (SC-CTV) with a gold-standard CTV...
8.
Nardone V, Reginelli A, Vinciguerra C, Correale P, Calvanese M, Falivene S, et al.
Front Psychol . 2021 Apr; 12:568839. PMID: 33815186
Novel coronavirus (COVID-19) is having a devastating psychological impact on patients, especially patients with cancer. This work aims to evaluate mood disorders of cancer patients undergoing radiation therapy during COVID-19...
9.
Gregucci F, Fozza A, Falivene S, Smaniotto D, Morra A, Daidone A, et al.
Radiol Med . 2020 Feb; 125(7):674-682. PMID: 32078120
Aims: To investigate the present attitude of the Italian Radiation Oncologists in the management of breast cancer (BC) concerning hypofractionated radiotherapy (hRT), partial-breast irradiation (PBI), re-irradiation (rRT) and radiotherapy after...
10.
Di Franco R, Borzillo V, Ravo V, Falivene S, Romano F, Muto M, et al.
Neuroradiol J . 2017 Dec; 31(1):18-26. PMID: 29206077
Objective The aim of this work was to evaluate the impact of stereotactic radiosurgery/fractionated stereotactic radiotherapy with the Cyberknife system on local disease control, clinical outcome and toxicity in patients...